303 related articles for article (PubMed ID: 15353502)
41. Association of plasma N-terminal pro-B-type natriuretic peptide with postoperative cardiac events in patients undergoing surgery for abdominal aortic aneurysm or leg bypass.
Feringa HH; Bax JJ; Elhendy A; de Jonge R; Lindemans J; Schouten O; van den Meiracker AH; Boersma E; Schinkel AF; Kertai MD; van Sambeek MR; Poldermans D
Am J Cardiol; 2006 Jul; 98(1):111-5. PubMed ID: 16784932
[TBL] [Abstract][Full Text] [Related]
42. Admission B-type natriuretic peptide assessment improves early risk stratification by Killip classes and TIMI risk score in patients with acute ST elevation myocardial infarction treated with primary angioplasty.
Grabowski M; Filipiak KJ; Malek LA; Karpinski G; Huczek Z; Stolarz P; Spiewak M; Kochman J; Rudowski R; Opolski G
Int J Cardiol; 2007 Feb; 115(3):386-90. PubMed ID: 16860415
[TBL] [Abstract][Full Text] [Related]
43. [Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension].
Nagaya N; Nishikimi T; Uematsu M; Satoh T; Kyotani S; Sakamaki F; Kakishita M; Fukushima K; Okano Y; Nakanishi N; Miyatake K; Kangawa K
J Cardiol; 2001 Feb; 37(2):110-1. PubMed ID: 11255693
[TBL] [Abstract][Full Text] [Related]
44. [Predictive value for long term cardiac events by admission B-type natriuretic peptide and pulmonary capillary wedge pressure in patients with chronic heart failure].
Hu YM; Wang M; Zhao SQ
Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Sep; 36(9):786-9. PubMed ID: 19102857
[TBL] [Abstract][Full Text] [Related]
45. Long-term prognostic value of B-type natriuretic peptide in cardiac and non-cardiac causes of acute dyspnoea.
Christ M; Thuerlimann A; Laule K; Klima T; Hochholzer W; Perruchoud AP; Mueller C
Eur J Clin Invest; 2007 Nov; 37(11):834-41. PubMed ID: 17931382
[TBL] [Abstract][Full Text] [Related]
46. B-type natriuretic peptide infusions in acute myocardial infarction.
Hillock RJ; Frampton CM; Yandle TG; Troughton RW; Lainchbury JG; Richards AM
Heart; 2008 May; 94(5):617-22. PubMed ID: 17639095
[TBL] [Abstract][Full Text] [Related]
47. Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial.
Omland T; Sabatine MS; Jablonski KA; Rice MM; Hsia J; Wergeland R; Landaas S; Rouleau JL; Domanski MJ; Hall C; Pfeffer MA; Braunwald E;
J Am Coll Cardiol; 2007 Jul; 50(3):205-14. PubMed ID: 17631211
[TBL] [Abstract][Full Text] [Related]
48. Clinical and prognostic value of Duke's Activity Status Index along with plasma B-type natriuretic peptide levels in chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
Parissis JT; Nikolaou M; Birmpa D; Farmakis D; Paraskevaidis I; Bistola V; Katsoulas T; Filippatos G; Kremastinos DT
Am J Cardiol; 2009 Jan; 103(1):73-5. PubMed ID: 19101233
[TBL] [Abstract][Full Text] [Related]
49. Neurohormonal risk stratification for sudden death and death owing to progressive heart failure in chronic heart failure.
Berger R; Huelsmann M; Strecker K; Moertl D; Moser P; Bojic A; Pacher R
Eur J Clin Invest; 2005 Jan; 35(1):24-31. PubMed ID: 15638816
[TBL] [Abstract][Full Text] [Related]
50. Plasma brain natriuretic peptide predicts short-term clinical outcome in heart failure patients with restrictive filling pattern.
Feola M; Aspromonte N; Milani L; Bobbio M; Bardellotto S; Barro S; Giovinazzo P; Noventa F; Valle R
J Card Fail; 2008 Jun; 14(5):420-5. PubMed ID: 18514935
[TBL] [Abstract][Full Text] [Related]
51. Usefulness of serum N-terminal pro-brain natriuretic peptide to predict in-stent restenosis in patients with preserved left ventricular function and normal troponin I levels.
Hong SN; Ahn Y; Yoon NS; Lee KH; Kim YS; Hwang SH; Lee SR; Kim KH; Park HW; Hong YJ; Kim JH; Jeong MH; Cho JG; Park JC; Kang JC
Am J Cardiol; 2007 Apr; 99(8):1051-4. PubMed ID: 17437726
[TBL] [Abstract][Full Text] [Related]
52. B-type natriuretic peptide is related to cardiac function and prognosis in hospitalized patients with decompensated cirrhosis.
Pimenta J; Paulo C; Gomes A; Silva S; Rocha-Gonçalves F; Bettencourt P
Liver Int; 2010 Aug; 30(7):1059-66. PubMed ID: 20492497
[TBL] [Abstract][Full Text] [Related]
53. Comparison of plasma B-type natriuretic peptide levels in single ventricle patients with systemic ventricle heart failure versus isolated cavopulmonary failure.
Law YM; Ettedgui J; Beerman L; Maisel A; Tofovic S
Am J Cardiol; 2006 Aug; 98(4):520-4. PubMed ID: 16893709
[TBL] [Abstract][Full Text] [Related]
54. B-type natriuretic Peptide-guided treatment for predicting outcome in patients hospitalized in sub-intensive care unit with acute heart failure.
Valle R; Aspromonte N; Giovinazzo P; Carbonieri E; Chiatto M; di Tano G; Feola M; Milli M; Fontebasso A; Barro S; Bardellotto S; Milani L
J Card Fail; 2008 Apr; 14(3):219-24. PubMed ID: 18381185
[TBL] [Abstract][Full Text] [Related]
55. B-type natriuretic peptide and amino terminal proBNP predict one-year mortality in short of breath patients independently of the baseline diagnosis of acute destabilized heart failure.
Gegenhuber A; Mueller T; Dieplinger B; Poelz W; Pacher R; Haltmayer M
Clin Chim Acta; 2006 Aug; 370(1-2):174-9. PubMed ID: 16600203
[TBL] [Abstract][Full Text] [Related]
56. Derived fibrinogen compared with C-reactive protein and brain natriuretic peptide for predicting events after myocardial infarction and coronary stenting.
Ketch TR; Turner SJ; Sacrinty MT; Lingle KC; Applegate RJ; Kutcher MA; Sane DC
Am Heart J; 2008 Aug; 156(2):234-40. PubMed ID: 18657651
[TBL] [Abstract][Full Text] [Related]
57. Vasoactive peptides during long-term follow-up of patients after cardiac transplantation.
Kirchhoff WCh; Gradaus R; Stypmann J; Deng MC; Tian TD; Scheld HH; Breithardt G; Brisse B
J Heart Lung Transplant; 2004 Mar; 23(3):284-8. PubMed ID: 15019637
[TBL] [Abstract][Full Text] [Related]
58. Plasma N-terminal pro-B-type natriuretic peptide for prediction of death or nonfatal myocardial infarction following percutaneous coronary intervention.
de Winter RJ; Stroobants A; Koch KT; Bax M; Schotborgh CE; Mulder KJ; Sanders GT; van Straalen JP; Fischer J; Tijssen JG; Piek JJ
Am J Cardiol; 2004 Dec; 94(12):1481-5. PubMed ID: 15589000
[TBL] [Abstract][Full Text] [Related]
59. Prognostic significance of the admission plasma B-type natriuretic peptide measurement in patients with first ST-elevation myocardial infarction in comparison with C-reactive protein and TIMI risk score.
Kuklinska AM; Sobkowicz B; Mroczko B; Sawicki R; Musial WJ; Knapp M; Dobrzycki S; Szmitkowski M
Clin Chim Acta; 2007 Jul; 382(1-2):106-11. PubMed ID: 17482153
[TBL] [Abstract][Full Text] [Related]
60. Prognostic utility of B-type natriuretic peptide assessment in stable low-risk outpatients with nonischemic cardiomyopathy after decompensated heart failure.
Nishii M; Inomata T; Takehana H; Naruke T; Yanagisawa T; Moriguchi M; Takeda S; Izumi T
J Am Coll Cardiol; 2008 Jun; 51(24):2329-35. PubMed ID: 18549918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
